| 注册
首页|期刊导航|中国临床药理学与治疗学|瘦素及其受体基因多态性与高血压相关性的Meta分析

瘦素及其受体基因多态性与高血压相关性的Meta分析

张晓宇 方正美 姚应水

中国临床药理学与治疗学2017,Vol.22Issue(8):910-916,7.
中国临床药理学与治疗学2017,Vol.22Issue(8):910-916,7.

瘦素及其受体基因多态性与高血压相关性的Meta分析

Association of leptin and leptin receptor gene polymorphisms with hypertension: a Meta-analysis

张晓宇 1方正美 1姚应水1

作者信息

  • 1. 皖南医学院公共卫生学院,芜湖241002,安徽
  • 折叠

摘要

Abstract

AIM:To evaluate the association between leptin gene and leptin receptor gene polymorphisms with hypertension.METHODS:CNKI,Wanfang database,Chongqing VIP network,Pubmed database and EMBASE database were researched.The data on the relationship between leptin/its receptor gene and hypertension were extracted and evaluated by software STATA11.0.RESULTS:Twenty-one studies involving 4 736 patients and 3 096 healthy people were included.The mcta-analysis showed the Ⅱ/Ⅰ polymorphism of LEP gene was associated with hypertension in recessive genetic model and additive genetic model (recessive genetic model:OR =2.16,95% CI =1.08-4.31,P =0.029,additive genetic model:OR =2.27,95% CI =1.08-4.79,P =0.031);the Gln223Arg polymorphism of LEPR gene was associated with hypertension in dominant model and allelic model (dominant model:OR =1.55,95%CI =1.14-2.11,P=0.005;allelic model:OR =1.36,95% CI =1.09-1.71,P =0.007).No statistically significant correlation was found between the Lysl09Arg polymorphism of LEPR gene and hypertension (dominant model:OR =0.87,95% CI =0.67-1.14,P =0.307,recessive genetic model:OR =0.91,95% CI =0.70-1.20,P =0.099,additive genetic model:OR =0.92,95%CI =0.70-1.21,P =0.071,allelic model:OR =1.04,95% CI =0.80-1.35,P =0.830).CONCLUSION:There is no significant correlation between Lys109Arg polymorphism of LEPR gene and hypertension,but the Ⅱ/Ⅰ polymorphism of LEP gene and Gln223Arg polymorphism of LEPR gene are associated with hypertension.

关键词

高血压/瘦素/瘦素受体/基因多态性/Meta分析

Key words

hypertension/leptin/leptin receptor/gene polymorphism/Meta-analysis

分类

医药卫生

引用本文复制引用

张晓宇,方正美,姚应水..瘦素及其受体基因多态性与高血压相关性的Meta分析[J].中国临床药理学与治疗学,2017,22(8):910-916,7.

基金项目

国家自然科学基金资助项目(81541071 ()

81072367) ()

中国临床药理学与治疗学

OACSCDCSTPCD

1009-2501

访问量0
|
下载量0
段落导航相关论文